The Delhi High Court set aside the ban on anti-inflammatory medicine “Ace Proxyvon”, used for painful rheumatic therapy, ruling that the centre’s decision to ban the drug had been taken with application of mind. Justice Vibhu Bhakru also said the ban order was passed without following certain procedures.
“Ace Proxyvon” was one of the 328 fixed dose combination (FDC) drugs banned by the Centre in September last year. The health ministry’s ban on FDCs included painkillers, anti-diabetic, respiratory and gastro-intestinal medicines, covering 6,000 brands.
FDCs are two or more drugs combined in a fixed ratio into a single dosage form.
This is the one of the first petitions against the centre’s ban order to be decided by the high court.